Author: Bajpai, Jyoti; Pradhan, Akshyaya; Singh, Abhishek; kant, Surya
Title: Hydroxychloroquine and COVID-19 – A narrative review Cord-id: hb4zey1w Document date: 2020_7_3
ID: hb4zey1w
Snippet: COVID 19 infection is unarguably the worst pandemic of this century. Till date there is no promising drug and vaccine available to treat this deadly viral infection. In the early phase chloroquine phosphate and hydroxychloroquine sulphate have been used to fight this illness on the basis of handful observational and small randomized and small-randomized studies. The paucity of clinical evidences of an unequivocal beneficial effect of chloroquine and hydroxychloroquine on COVID-19 has resulted in
Document: COVID 19 infection is unarguably the worst pandemic of this century. Till date there is no promising drug and vaccine available to treat this deadly viral infection. In the early phase chloroquine phosphate and hydroxychloroquine sulphate have been used to fight this illness on the basis of handful observational and small randomized and small-randomized studies. The paucity of clinical evidences of an unequivocal beneficial effect of chloroquine and hydroxychloroquine on COVID-19 has resulted in the passionate use of the drug for moderate to severe cases only and stimulated the need for large clinical trials for this and other molecules. In this review, we describe in brief the mechanism of action, the clinical studies, factors for cardiac toxicity, guidelines and future directions for hydroxychloroquine use in management of COVID-19 infection.
Search related documents:
Co phrase search for related documents- action mechanism and additional research: 1, 2, 3
- action mechanism and liver kidney: 1, 2, 3, 4, 5
- action mechanism and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute respiratory syndrome and additional avenue: 1
- acute respiratory syndrome and additional research: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and local guideline: 1
- acute respiratory syndrome and long qt syndrome: 1, 2
- acute respiratory syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome develop and liver kidney: 1, 2, 3, 4
- acute respiratory syndrome develop and lopinavir ritonavir: 1
- additional research and liver kidney: 1
- additional research and lopinavir ritonavir: 1, 2
- liver kidney and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- long qt syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date